- Home
- CLNN vs SRTS Comparison
CLNN vs SRTS Comparison
Compare CLNN & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- SRTS
- Stock Information
- Founded
- CLNN 2012
- SRTS 2010
- Country
- CLNN United States
- SRTS United States
- Employees
- CLNN N/A
- SRTS N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- SRTS Medical/Dental Instruments
- Sector
- CLNN Health Care
- SRTS Health Care
- Exchange
- CLNN Nasdaq
- SRTS Nasdaq
- Market Cap
- CLNN 60.3M
- SRTS 51.8M
- IPO Year
- CLNN N/A
- SRTS 2016
- Fundamental
- Price
- CLNN $9.42
- SRTS $3.45
- Analyst Decision
- CLNN Strong Buy
- SRTS Strong Buy
- Analyst Count
- CLNN 6
- SRTS 3
- Target Price
- CLNN $32.67
- SRTS $8.00
- AVG Volume (30 Days)
- CLNN 149.6K
- SRTS 88.0K
- Earning Date
- CLNN 11-12-2025
- SRTS 11-13-2025
- Dividend Yield
- CLNN N/A
- SRTS N/A
- EPS Growth
- CLNN N/A
- SRTS N/A
- EPS
- CLNN N/A
- SRTS N/A
- Revenue
- CLNN $286,000.00
- SRTS $37,564,000.00
- Revenue This Year
- CLNN N/A
- SRTS N/A
- Revenue Next Year
- CLNN $1,363.77
- SRTS $46.14
- P/E Ratio
- CLNN N/A
- SRTS N/A
- Revenue Growth
- CLNN N/A
- SRTS 3.29
- 52 Week Low
- CLNN $2.28
- SRTS $3.03
- 52 Week High
- CLNN $11.06
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- CLNN 66.11
- SRTS 56.63
- Support Level
- CLNN $8.54
- SRTS $3.11
- Resistance Level
- CLNN $11.00
- SRTS $3.68
- Average True Range (ATR)
- CLNN 0.83
- SRTS 0.12
- MACD
- CLNN 0.29
- SRTS 0.09
- Stochastic Oscillator
- CLNN 62.27
- SRTS 75.32
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.